scholarly journals Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase

2009 ◽  
Vol 104 (3) ◽  
pp. 346-354 ◽  
Author(s):  
Price Blair ◽  
Sybille Rex ◽  
Olga Vitseva ◽  
Lea Beaulieu ◽  
Kahraman Tanriverdi ◽  
...  
Bone ◽  
2011 ◽  
Vol 48 ◽  
pp. S125
Author(s):  
A. Kassem⁎ ◽  
P.C. Souza ◽  
P. Lundberg ◽  
U.H. Lerner

2004 ◽  
Vol 172 (9) ◽  
pp. 5727-5733 ◽  
Author(s):  
Derek Strassheim ◽  
Karim Asehnoune ◽  
Jong-Sung Park ◽  
Jae-Yeol Kim ◽  
Qianbin He ◽  
...  

2009 ◽  
Vol 17 (8) ◽  
pp. 662-670 ◽  
Author(s):  
Simon Heuking ◽  
Sarah Adam-Malpel ◽  
Emmanuelle Sublet ◽  
Antonio Iannitelli ◽  
Antonio di Stefano ◽  
...  

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Chuanfu Li ◽  
Fang Hua ◽  
Tuanzhu Ha ◽  
Jing Ma ◽  
Jim Kelley ◽  
...  

Activation of the phosphoinositide-3 kinase/Akt (PI3K/Akt) signaling pathway protects cells from ischemic injury. We have reported that the immune modulator, glucan, rapidly induces cardioprotection. Dectin-1 is a specific receptor for glucan and Toll-like receptor 2 (TLR2) is required for transmitting the signal from Dectin-1 into cells. However, the role of modulation of TLR2 in cardioprotection has not been investigated. We hypothesized that modulation of TLR2 will induce cardioprotection through a PI3K/Akt-dependent mechanism. To evaluate our hypothesis, we examined the effect of modulation of TLR2 on myocardial ischemic injury. TLR2 knockout (KO) (n=8) and wild type mice (n=8) were treated with glucan (1 mg/25g) or peptidoglycan (PDG, 75 μg/25g), a specific TLR2 ligand, one hr before the hearts were subjected to ischemia (1 hr)/reperfusion (4 hrs). Untreated mice (n=8) were also subjected to I/R. Myocardial infarction was determined by TTC staining. Infarct size was significantly reduced in glucan (11.6 ± 2.38% vs 36.1 ± 3.48%, p<0.01) and PDG (10.5 ± 3.03% vs 30.1 ± 7.59%, p<0.01) treated mice vs untreated mice. The levels of phospho-Akt (0.80 ± 0.10 vs 0.45 ± 0.09) and phospho-GSK3β (0.66 ± 0.14 vs 0.33 ± 0.10) were significantly increased in the myocardium of glucan treated mice compared with untreated mice. However, both glucan and PDG-induced cardioprotection were completely abolished in TLR2 KO mice. To investigate whether PI3K/Akt signaling is involved in cardioprotection induced by modulation of TLR2, we administered glucan (1 mg/25g) or PDG (75 μg/25g) to kdAkt (kinase deficient Akt) transgenic mice (n=8) one hr before myocardial I/R. Both glucan and PDG-induced cardioprotection were completely abolished in kdAkt mice. The results suggest that modulation of TLR2, either directly or indirectly, will induce cardioprotection through a PI3K/Akt dependent mechanism and that there is a critical link between TLR2 and PI3K/Akt signaling during myocardial I/R.


Resuscitation ◽  
2012 ◽  
Vol 83 (11) ◽  
pp. 1404-1410 ◽  
Author(s):  
Jan Mersmann ◽  
Nguyen Tran ◽  
Kathrina Latsch ◽  
Katharina Habeck ◽  
Franziska Iskandar ◽  
...  

2010 ◽  
Vol 51 (1) ◽  
pp. 459 ◽  
Author(s):  
Thomas G. Hauk ◽  
Marco Leibinger ◽  
Adrienne Müller ◽  
Anastasia Andreadaki ◽  
Uwe Knippschild ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (19) ◽  
pp. 4782
Author(s):  
Jacqueline E Mann ◽  
Megan L Ludwig ◽  
Aditi Kulkarni ◽  
Erin B Scheftz ◽  
Isabel R Murray ◽  
...  

As immunotherapies targeting the PDL1 checkpoint have become a mainstay of treatment for a subset of head and neck squamous cell carcinoma (HNSCC) patients, a detailed understanding of the mechanisms underlying PDL1-mediated immune evasion is needed. To elucidate factors regulating expression of PDL1 in HNSCC cells, a genome-wide CRISPR profiling approach was implemented to identify genes and pathways conferring altered PDL1 expression in an HNSCC cell line model. Our screen nominated several candidate PDL1 drivers, including Toll-like Receptor 2 (TLR2). Depletion of TLR2 blocks interferon-γ-induced PDL1 expression, and stimulation of TLR2 with either Staphylococcus aureus or a bacterial lipopeptide mimetic, Pam3CSK4, enhanced PDL1 expression in multiple models. The data herein demonstrate a role for TLR2 in modulating the expression of PDL1 in HNSCC models and suggest that microbiota may directly modulate immunosuppression in cancer cells. Our study represents a step toward disentangling the diverse pathways and stimuli regulating PDL1 expression in HNSCC and underscores a need for future work to characterize the complex microbiome in HNSCC patients treated with immunotherapy.


Sign in / Sign up

Export Citation Format

Share Document